8- NCT043
36,254 Safety and Efficacy
Study of Allogeneic
Human Dental Pulp
Mesenchymal Stem
Cells to Treat Severe
COVID19 Patients I and II Recruiting 20 DPSCs DOS: April 2020
DOC: March
2021 Both 18 to 65 Yrs. China